Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
CD9 Counteracts Liver Steatosis and Mediates GCGR Agonist Hepatic Effects
CD9 Counteracts Liver Steatosis and Mediates GCGR Agonist Hepatic Effects
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Yi Zheng
,
Yuren Wang
,
Xin Xiong
,
Linlin Zhang
,
Jiaran Zhu
,
Bangliang Huang
,
Xiufei Liu
,
Jinbo Liu
,
Zhiming Zhu
,
Gangyi Yang
,
Hua Qu
,
Hongting Zheng
Format:
Artículo Open Access
Published:
Wiley
2024
Subjects:
Advanced Science
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Internet
https://advanced.onlinelibrary.wiley.com/doi/10.1002/advs.202400819
Similar Items
Liraglutide Promotes Diabetic Wound Healing via Myo1c/Dock5
by: Qian Zhang, et al.
Published: (2024)
Exosome‐Delivered eNAMPT From Exercise Activates SIRT1 to Counteract Age‐Related Hepatic Steatosis and Fibrosis
by: Wenxuan Song, et al.
Published: (2026)
Hepatic GCGR is required for the superior weight loss and metabolic effects of a structurally related analogue of the dual GCGR / GLP ‐ 1R agonist survodutide in mice
by: Fen Long, et al.
Published: (2025)
Hepatic Steatosis and Fibrosis, Cardiorespiratory Fitness, and Metabolic Mediators in the Community
by: Victor V. Florea, et al.
Published: (2024)
External Validation of the Hepatic Steatosis Index for the Detection of Steatotic Liver Disease in Zambia
by: Carlotta Mondoka, et al.
Published: (2025)